Argenx SE Net Income Growth & History (ARGX)
Argenx SE's net income was $1.29B for fiscal 2025.
View full Argenx SE company overviewArgenx SE annual net income history
| Fiscal year | Period ended | Net income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.29B | $459.0M | +55.10% |
| 2024 | 2024-12-31 | $833.0M | $1.13B | — |
| 2023 | 2023-12-31 | −$295.1M | $414.5M | — |
| 2022 | 2022-12-31 | −$709.6M | −$301.3M | — |
| 2021 | 2021-12-31 | −$408.3M | $200.2M | — |
| 2020 | 2020-12-31 | −$608.5M | −$427.2M | — |
| 2019 | 2019-12-31 | −$181.2M | −$114.6M | — |
| 2018 | 2018-12-31 | −$66.6M | — | — |
Argenx SE quarterly net income
| Fiscal quarter | Period ended | Net income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $472.0M | $226.6M | +92.37% |
| Q1 2026 | 2026-03-31 | $366.0M | — | — |
| Q4 2025 | 2025-12-31 | $533.0M | — | — |
| Q3 2025 | 2025-09-30 | $344.3M | — | — |
| Q2 2025 | 2025-06-30 | $245.4M | — | — |
Argenx SE net income trends
Over the last five fiscal years, Argenx SE's net income increased from −$608.5M to $1.29B, a change of $1.90B. The latest reported quarter, Q2 2026, shows $472.0M.
What net income means
Net income is a company’s bottom-line profit or loss after operating costs, interest, taxes, and other reported income and expenses. It shows how much of a company’s revenue ultimately remained as earnings, or how large its loss was, during a fiscal period.
SEC-reported net income
TickerStat standardizes consolidated net income or profit and loss reported in company SEC filings for aligned fiscal periods. It is not adjusted earnings, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Argenx SE source filings ↗Community posts
Argenx sales expand as additional clinical and regulatory work advances
Argenx ($ARGX) reported third-quarter 2026 product sales of approximately $1.7 billion, an increase of 54% from a year earlier and 13% from the preceding quarter. Net profit attributable to shareholders increased to $506 million from $344 m ...